IP Library › Granted Patent US 8,512,992
Granted Patent B2
US 8,512,992 · App. 13/112,844 · Granted Aug 20, 2013

Degradable clostridial toxins

Inventors: Lance E. Steward (Irvine, CA); Sanjiv Ghanshani (Irvine, CA); Ester Fernandez-Salas (Fullerton, CA); Marcella A. Gilmore (Santa Ana, CA); Joseph Francis (Aliso Viejo, CA); Kei Roger Aoki (Coto de Caza, CA)
Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,992
App. No.
13/112,844
Granted
Aug 20, 2013
Kind
B2
Abstract

The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras.

Claims (1)

1. An isolated Clostridial toxin comprising SEQ ID NO: 531.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2011
From: STEWARD, LANCE E.; GHANSHANI, SANJIV; FERNANDEZ-SALAS, ESTER; GILMORE, MARCELLA A.; FRANCIS, JOSEPH; AOKI, KEI ROGER
To: ALLERGAN, INC.
Reel/Frame 026523/0062 →
Continuity (2)
Provisional Application 61346578 · May 20, 2010
Related Publication 20110287517A1 · Nov 24, 2011